Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinum toxin A injection at the sphenopalatine ganglion for trigeminal neuralgia
TCTR20240908004Completed
- Sponsor
- Nil
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of onabotulinumtoxinA in trigeminal neuralgia (TN), sponsored by Nil. Started Jul 2023; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on TCTR20240908004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240908004.